View Author
Berger, J.
(Jürgen Berger)
troponin patient level percent abciximab troponin t levels event troponin t serum milliliter placebo infarction treatment angina value serum troponin t copyright 1999 massachusetts randomization odds ratio benefit event rates study group death month event rate ratio 0.12 ng follow-up point trial ck-mb interval m t r confidence b i n cutoff level analysis percutaneous transluminal placebo group angioplasty 6 months cutoff time points chest pain 72 hours ck-mb level disease troponin tpositive patients 0.12 erasmu troponin t values period society troponin tnegative patients massachusett nonfatal troponin t level www.nejm.org universiteit troponin i 36 hours october 24 hours artery disease 5.0 ng 0.1 figure table 0.1 ng interaction 23.9 percent downloaded medisch prognostic value right 30 days serum samples biblio copyright
1 Most Recent Publications
|
Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels.
(Article)
Hamm, C.W. Heeschen, C. Goldmann, B. Vahanian, A. Adgey, J. Macaya Miguel, C.M. Rutsch, W.R. Berger, J. Kootstra, J.G. Simoons, M.L. |
1999-01-01
|